Skip to search.
 FTSE 100 Up 0.36%

Gilead Sciences Inc. (GILD)

-NasdaqGS
105.01 Up 4.50(4.48%) 1 May 21:00
|Pre-Market : 105.50 Up 0.49 (0.47%) 13:04 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:100.51
Open:103.20
Bid:105.46 x 200
Ask:105.50 x 400
1y Target Est:118.90
Beta:0.9
Earnings Date:21 Jul - 27 Jul (Est.)
Day's Range:102.50 - 106.34
52wk Range:76.63 - 116.83
Volume:22,320,424
Avg Vol (3m):11,751,100
Market Cap:155.74b
P/E (ttm):14.29
EPS (ttm):7.35
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 4.48%155.74b
GSKDown 0.39%110.58b
PFEUp 0.44%209.26b
RHHBYUp 0.45%N/A

Key Statistics

Forward P/E (1 yr):9.69
P/S (ttm):6.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.38
Quarterly EPS Est (Jun-15) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback